Kevin Boyle | executive |
Drew Deniger | executive |
Michael Wong | executive |
Chris Howerton | analyst |
Yu He | analyst |
Thomas Flaten | analyst |
Yale Jen | analyst |
Ladies and gentlemen, thank you for standing by, and welcome to the Alaunos Therapeutics Fourth Quarter and Full Year 2021 Financial Results Conference Call. [Operator Instructions]
I would now like to turn the call over to your host, Alex Lobo, Stern Investor Relations.
You may begin.
Good morning, and welcome to Alaunos Therapeutics Fourth Quarter and Full Year 2021 Financial Results Conference Call and Audio Webcast.